Literature DB >> 33275722

Women and bleeding disorders: diagnostic challenges.

Paula D James1.   

Abstract

Women with bleeding disorders suffer from multiple bleeding symptoms, including easy bruising, epistaxis, bleeding from minor wounds and the oral cavity, and bleeding after dental work or surgery. However, women with bleeding disorders especially suffer from gynecologic and obstetrical bleeding. These symptoms often are not recognized as abnormal, and many women are left undiagnosed and without access to appropriate medical care. Additional challenges to diagnosing women with bleeding disorders include lack of access to appropriate laboratory testing and issues around disease classification and nomenclature. Efforts have been undertaken to address these challenges, including the development and validation of bleeding assessment tools and strategies to clarify diagnostic thresholds and algorithms for von Willebrand disease (VWD) and platelet function disorders. Efforts to improve communication with the nomenclature used for hemophilia carriers are also underway.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2020        PMID: 33275722      PMCID: PMC7727580          DOI: 10.1182/hematology.2020000140

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  44 in total

Review 1.  Impact, diagnosis and treatment of von Willebrand disease.

Authors:  J E Sadler; P M Mannucci; E Berntorp; N Bochkov; V Boulyjenkov; D Ginsburg; D Meyer; I Peake; F Rodeghiero; A Srivastava
Journal:  Thromb Haemost       Date:  2000-08       Impact factor: 5.249

2.  Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life.

Authors:  C Rae; W Furlong; J Horsman; E Pullenayegum; C Demers; J St-Louis; D Lillicrap; R Barr
Journal:  Haemophilia       Date:  2012-09-21       Impact factor: 4.287

3.  Haemophilia A carriers demonstrate pathological and radiological evidence of structural joint changes.

Authors:  L Gilbert; L Rollins; M Hilmes; Y Luo; D Gailani; M R Debaun; R F Sidonio
Journal:  Haemophilia       Date:  2014-09-23       Impact factor: 4.287

4.  Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival.

Authors:  Sandra L Haberichter; Michael Balistreri; Pamela Christopherson; Patricia Morateck; Stefana Gavazova; Daniel B Bellissimo; Marilyn J Manco-Johnson; Joan Cox Gill; Robert R Montgomery
Journal:  Blood       Date:  2006-07-11       Impact factor: 22.113

Review 5.  Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.

Authors:  J E Sadler; U Budde; J C J Eikenboom; E J Favaloro; F G H Hill; L Holmberg; J Ingerslev; C A Lee; D Lillicrap; P M Mannucci; C Mazurier; D Meyer; W L Nichols; M Nishino; I R Peake; F Rodeghiero; R Schneppenheim; Z M Ruggeri; A Srivastava; R R Montgomery; A B Federici
Journal:  J Thromb Haemost       Date:  2006-08-02       Impact factor: 5.824

6.  Association between phenotype and genotype in carriers of haemophilia A.

Authors:  W Miesbach; S Alesci; C Geisen; J Oldenburg
Journal:  Haemophilia       Date:  2010-12-01       Impact factor: 4.287

7.  Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study.

Authors:  P D James; J Mahlangu; C Bidlingmaier; M E Mingot-Castellano; M Chitlur; P F Fogarty; A Cuker; M E Mancuso; P A Holme; J Grabell; N Satkunam; W M Hopman; P Mathew
Journal:  Haemophilia       Date:  2016-11       Impact factor: 4.287

Review 8.  Menorrhagia: an update.

Authors:  M K Oehler; M C P Rees
Journal:  Acta Obstet Gynecol Scand       Date:  2003-05       Impact factor: 3.636

9.  Management of carriers and babies with haemophilia.

Authors:  A M Street; R Ljung; S A Lavery
Journal:  Haemophilia       Date:  2008-07       Impact factor: 4.287

10.  Menorrhagia II: is the 80-mL blood loss criterion useful in management of complaint of menorrhagia?

Authors:  Pamela E Warner; Hilary O D Critchley; Mary Ann Lumsden; Mary Campbell-Brown; Anne Douglas; Gordon D Murray
Journal:  Am J Obstet Gynecol       Date:  2004-05       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.